CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong · Delayed Price · Currency is HKD 0.7300
-0.0100 (-1.35%)
Apr 17, 2026, 10:37 AM HKT
CK Life Sciences Int'l., (Holdings) Employees
CK Life Sciences Int'l., (Holdings) had 1,920 employees as of December 31, 2025. The number of employees decreased by 113 or -5.56% compared to the previous year.
Employees
1,920
Change (1Y)
-113
Growth (1Y)
-5.56%
Revenue / Employee
2.82M HKD
Profits / Employee
-97.29K HKD
Market Cap
7.11B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,920 | -113 | -5.56% |
| Dec 31, 2024 | 2,033 | 101 | 5.23% |
| Dec 31, 2023 | 1,932 | 76 | 4.09% |
| Dec 31, 2022 | 1,856 | 1 | 0.05% |
| Dec 31, 2021 | 1,855 | 46 | 2.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,156 |
| Shandong Boan Biotechnology | 714 |
| Lepu Biopharma | 546 |
| Ocumension Therapeutics | 505 |
| Alphamab Oncology | 498 |
| Qyuns Therapeutics | 337 |
| Abbisko Cayman | 226 |
| Beijing Luzhu Biotechnology | 205 |
CK Life Sciences Int'l., (Holdings) News
- 18 days ago - Li Ka-shing’s CK Life unit eyes China fast track for cancer vaccine pipeline - South China Morning Post
- 6 months ago - CK Life unit merges with TransCode as Li Ka-shing firm eyes anticancer drugs - South China Morning Post
- 6 months ago - TransCode Acquires Polynoma From CK Life Sciences - Nasdaq
- 1 year ago - CK Life’s new CEO counts on Big Pharma experience to boost new drug success, earnings - South China Morning Post